Nigral Iron Elevation Is an Invariable Feature of Parkinson's Disease and Is a Sufficient Cause of Neurodegeneration

被引:176
作者
Ayton, Scott [1 ]
Lei, Peng [1 ]
机构
[1] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3010, Australia
基金
英国医学研究理事会;
关键词
SUBSTANTIA-NIGRA; ALPHA-SYNUCLEIN; BRAIN IRON; FERROXIDASE ACTIVITY; TRANSCRANIAL SONOGRAPHY; CERULOPLASMIN GENE; SUPEROXIDE-DISMUTASE; ALZHEIMERS-DISEASE; LIPID-PEROXIDATION; SELECTIVE INCREASE;
D O I
10.1155/2014/581256
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 [微生物学]; 090105 [作物生产系统与生态工程];
摘要
Parkinson's disease (PD) is a neurodegenerative disorder characterized by motor deficits accompanying degeneration of substantia nigra pars compactor (SNc) neurons. Although familial forms of the disease exist, the cause of sporadic PD is unknown. Symptomatic treatments are available for PD, but there are no disease modifying therapies. While the neurodegenerative processes in PD may be multifactorial, this paper will review the evidence that prooxidant iron elevation in the SNc is an invariable feature of sporadic and familial PD forms, participates in the disease mechanism, and presents as a tractable target for a disease modifying therapy.
引用
收藏
页数:9
相关论文
共 134 条
[1]
Prevalence of haemochromatosis gene mutations in Parkinson's disease [J].
Aamodt, Anne Hege ;
Stovner, Lars Jacob ;
Thorstensen, Ketil ;
Lydersen, Stian ;
White, Linda R. ;
Aasly, Jan O. .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2007, 78 (03) :315-317
[2]
Screening for mutations of the HFE gene in Parkinson's disease patients with hyperechogenicity of the substantia nigra [J].
Akbas, Nilguen ;
Hochstrasser, Helmine ;
Deplazes, Joelle ;
Tomiuk, Juergen ;
Bauer, Peter ;
Walter, Uwe ;
Behnke, Stefanie ;
Riess, Olaf ;
Berg, Daniela .
NEUROSCIENCE LETTERS, 2006, 407 (01) :16-19
[3]
Oxidative DNA damage in the parkinsonian brain: An apparent selective increase in 8-hydroxyguanine levels in substantia nigra [J].
Alam, ZI ;
Jenner, A ;
Daniel, SE ;
Lees, AJ ;
Cairns, N ;
Marsden, CD ;
Jenner, P ;
Halliwell, B .
JOURNAL OF NEUROCHEMISTRY, 1997, 69 (03) :1196-1203
[4]
LATE ONSET PARKINSONIAN SYNDROME IN HALLERVORDEN-SPATZ DISEASE [J].
ALBERCA, R ;
RAFEL, E ;
CHINCHON, I ;
VADILLO, J ;
NAVARRO, A .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1987, 50 (12) :1665-1668
[5]
Lewy body in neurodegeneration with brain iron accumulation type 1 is immunoreactive for α-synuclein [J].
Arawaka, S ;
Saito, Y ;
Murayama, S ;
Mori, H .
NEUROLOGY, 1998, 51 (03) :887-889
[6]
Atasoy HT, 2004, NEUROL INDIA, V52, P332
[7]
Metallostasis in Alzheimer's disease [J].
Ayton, Scott ;
Lei, Peng ;
Bush, Ashley I. .
FREE RADICAL BIOLOGY AND MEDICINE, 2013, 62 :76-89
[8]
Ceruloplasmin dysfunction and therapeutic potential for Parkinson disease [J].
Ayton, Scott ;
Lei, Peng ;
Duce, James A. ;
Wong, Bruce X. W. ;
Sedjahtera, Amelia ;
Adlard, Paul A. ;
Bush, Ashley I. ;
Finkelstein, David I. .
ANNALS OF NEUROLOGY, 2013, 73 (04) :554-559
[9]
Neurodegenerative diseases and oxidative stress [J].
Barnham, KJ ;
Masters, CL ;
Bush, AI .
NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (03) :205-214
[10]
Kupffer cell staining by an HFE-specific monoclonal antibody: implications for hereditary haemochromatosis [J].
Bastin, JM ;
Jones, M ;
O'Callaghan, CA ;
Schimanski, L ;
Mason, DY ;
Townsend, ARM .
BRITISH JOURNAL OF HAEMATOLOGY, 1998, 103 (04) :931-941